Panobinostat is a pan-HDAC inhibitor that has been found to inhibit tumor cell proliferation, induce alternative pathways of apoptosis [91] and promote a more differentiated and less invasive phenotype in HCC cells [92]. This evidence concerns the gene HDAC9 and hepatocellular carcinoma.